Kajian klinikal Hemofilia di Florida
6 kajian untuk Hemofilia sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT05568719A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- St Joseph's Children's Hospital of Tampa, Tampa
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- dan 4 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Johns Hopkins All Children's Hospital, St. Petersburg
Mengambil pesertaKajian pemerhatian
Umur 6 hingga 19 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05022459Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- University of Miami Miller School of Medicine, Miami
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 2 Jun 2026 · NCT03695978Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Miami - Miller School of Medicine, Coral Gables
- St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders, Tampa
Mengambil pesertaFasa 1
Umur 0 hingga 90 · Semua jantina · Dikemas kini 3 Apr 2026 · NCT05500807Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.